Disease/Infection News

RSS

Positive results from Puricore's Vashe Wound Therapy efficacy trial

PuriCore, the life sciences company focused on developing and commercializing proprietary solutions that safely, effectively, and naturally kill infectious pathogens, today announced results of a randomized clinical trial showing the potential effectiveness of its Vashe Wound Therapy in the post-operative care of split-thickness skin grafts for burn injuries.

11 Nov 2009

Cholesterol-lowering drugs associated with reduced risk of gallstone disease

Use of the cholesterol-lowering drugs statins for more than a year is associated with a reduced risk of having gallstones requiring surgery, according to a study in the November 11 issue of JAMA.

11 Nov 2009

Hand washing: Best method for killing germs and protecting oneself from flu

Fears of contracting the H1N1 virus this flu season have people steering clear of strangers with coughs and scolding friends who don't sneeze into their crooked elbows. With everyone trying to stay germ free, hand sanitizer has become a popular means of protection. But although a quick pump from a Purell dispenser is the most convenient form of hand cleaning, is it the best?

11 Nov 2009

$9M ARRA funds to reduce healthcare-associated infections in ambulatory surgical centers

To reduce healthcare-associated infections (HAIs) in stand-alone or same-day surgical centers, the HHS Secretary Kathleen Sebelius today announced the availability of up to $9 million in funding from the American Recovery and Reinvestment Act (ARRA) to state survey agencies in 43 states. HAIs are infections some patients acquire when they are in a health care setting such as a hospital or outpatient clinic.

11 Nov 2009

UIC receives federal grant to develop new antibiotics against anthrax, tularemia and plague

Researchers at the University of Illinois at Chicago have received a $4 million federal grant to develop new antibiotics to treat anthrax, tularemia and plague.

11 Nov 2009

World's poorest countries fail to address HIV despite low cost and effective preventive health efforts

A proven and cost-effective strategy for turning the tide on global AIDS still remains significantly underutilized, World Vision warned in advance of World AIDS Day. Efforts to prevent mother-to-baby transmission of HIV must be urgently scaled up in high-prevalence countries to avoid needless infection of children, the Christian humanitarian organization said.

11 Nov 2009

Lower socioeconomic status linked with inability to fight H1N1

People who did not earn a high school diploma could be more likely to get H1N1 and the vaccine might be less effective in them compared to those who earned a diploma, new research shows.

11 Nov 2009

Majority of pharmacists say patients should use OTC drugs at the first sign of cold and flu symptoms

A recent national survey of 505 pharmacists found that nine out of 10 pharmacists believe it is important for a patient to seek treatment early to help shorten the duration and severity of a cold.

11 Nov 2009

Healthpoint to launch ULTRACEPT Antiseptic Handwash

A new antiseptic handwash, based on a formula previously used only by surgeons and other clinicians, will soon be available to consumers and provides up to six hours of prolonged germ kill with repeated use.

11 Nov 2009

New visitation guidelines to prevent novel flu spread

The New Jersey Hospital Association has issued new visitation guidelines for the state's hospitals to help them protect patients, staff and visitors from H1N1 influenza.

11 Nov 2009

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.

11 Nov 2009

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

Academic Health Center scientists, physicians, and research centers have attracted 128 grants totaling nearly $35 million in federal stimulus money (as of Nov. 10) since the American Recovery and Reinvestment Act was approved in February 2009. This will result in a total economic impact of more than $105 million; according to the National Institutes of Health, $1 of research funding multiplies to more than $2 of goods and services in the economy.

11 Nov 2009

Also in Global Health: Child sexual abuse in Zimbabwe; dengue outbreak in Cape Verde; program reduces waste in Kenya slums

The Mail & Guardian examines how the "economic collapse" in Zimbabwe has contributed to rising numbers of children falling victims to sexual abuse. "A single clinic in the capital, Harare, says it has treated nearly 30,000 girls and boys who were abused in the past four years - an average of 20 per day." The article examines other contributing factors to the sexual abuse of children in Zimbabwe and a recent program that aims to make schools safe places for Zimbabwe's children (11/10).

11 Nov 2009

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

In follow-up coverage to the WHO's report on women's health, several news outlets examine the impact HIV/AIDS is having on women around the world. "In its first study of women's health, the World Health Organization said yesterday that the AIDS virus is the leading cause of death and disease among women between the ages of 15 and 44," the Associated Press/Boston Globe reports (11/10).

11 Nov 2009

Study: Patients with difficult to treat hepatitis C are half as likely to initiate treatment

A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. Marital status also affected whether patients chose treatment, as did whether or not they had other diseases.

10 Nov 2009

Study on how robust antibodies work to block the HIV virus raise hope for new vaccine

A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine.

10 Nov 2009

Researcers identify a new array of genes in GAS

Group A streptococcus (GAS) is a human pathogenic bacteria. Many people carry GAS asymptomatically in their upper respiratory tract and other anatomic sites. However, these bacteria can cause a variety of human diseases ranging from superficial skin and throat infections to highly invasive life-threatening diseases such as toxic shock and necrotizing fasciitis, commonly known as the flesh-eating bacteria.

10 Nov 2009

Speaker Pelosi praises H.R. 3962 that will improve Medicaid access to HIV/AIDS-affected people

"Effective drug treatments have improved both health and quality of life for thousands of Americans living with HIV/AIDS. However, many uninsured, low-income HIV-positive individuals still do not have access to these life-saving medications because they generally do not meet Medicaid requirements until becoming disabled by full-blown AIDS.

10 Nov 2009

New N95 respirator from Safe Life

Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies that prevent the spread of infection and disease, announced today the availability of the Safe Life A400 Series N95 Respirator with Antimicrobial Protection.

10 Nov 2009

Human movement is a key factor for dengue spread in Brazil

Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. The results, based on data from a severe epidemic in 2007-2008, contribute to new understanding on the dynamics of dengue fever in the second largest city in Brazil. Details are published November 10 in the open-access journal PLoS Neglected Tropical Diseases.

10 Nov 2009

Disease/Infection News

Positive results from Puricore's Vashe Wound Therapy efficacy trial

Cholesterol-lowering drugs associated with reduced risk of gallstone disease

Hand washing: Best method for killing germs and protecting oneself from flu

$9M ARRA funds to reduce healthcare-associated infections in ambulatory surgical centers

UIC receives federal grant to develop new antibiotics against anthrax, tularemia and plague

World's poorest countries fail to address HIV despite low cost and effective preventive health efforts

Lower socioeconomic status linked with inability to fight H1N1

Majority of pharmacists say patients should use OTC drugs at the first sign of cold and flu symptoms

Healthpoint to launch ULTRACEPT Antiseptic Handwash

New visitation guidelines to prevent novel flu spread

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

Also in Global Health: Child sexual abuse in Zimbabwe; dengue outbreak in Cape Verde; program reduces waste in Kenya slums

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

Study: Patients with difficult to treat hepatitis C are half as likely to initiate treatment

Study on how robust antibodies work to block the HIV virus raise hope for new vaccine

Researcers identify a new array of genes in GAS

Speaker Pelosi praises H.R. 3962 that will improve Medicaid access to HIV/AIDS-affected people

New N95 respirator from Safe Life

Human movement is a key factor for dengue spread in Brazil

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News